- Investing Ideas
- /
- Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Pakistani Pharmaceuticals & Biotech Undiscovered Gems With Strong Fundamentals
Results
4
High-performing small cap companies that haven't yet garnered significant analyst attention, and could lead to superior returns.
4 companies
GlaxoSmithKline Pakistan
Market Cap: PK₨148.8b
Operates as a biopharma company in Pakistan.
GLAXO
PK₨467.12
7D
2.6%
1Y
372.4%
Hoechst Pakistan
Market Cap: PK₨30.5b
Engages in the manufacture, trading, and sale of pharmaceutical and related products in Pakistan, Afghanistan, and internationally.
HPL
PK₨3,158.50
7D
-2.5%
1Y
125.6%
Highnoon Laboratories
Market Cap: PK₨49.6b
Manufactures, imports, sells, exports, and markets pharmaceutical and allied consumer products.
HINOON
PK₨935.50
7D
-4.4%
1Y
74.4%
Abbott Laboratories (Pakistan)
Market Cap: PK₨104.0b
Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.
ABOT
PK₨1,062.06
7D
-0.1%
1Y
93.1%